
5 tips to reduce the liability risk of prescribing GLP-1s
An action plan for physicians to protect themselves against malpractice litigation related to medications like Ozempic.
As a
Max Schloemann is the founder of
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.


















